Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Cardiovascular Conditions
    • Commentary
    • Dermatological Diseases
    • Endocrine Diseases
    • Gastrointestinal Conditions
    • General Indications
    • Hematology
    • Hereditary Genetic Disorders
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Nephrologic/Hepatologic Conditions
    • Neurological Diseases
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search

    Sorry, something went wrong. Please try your search again.
    ×

    • Articles
    • Blog posts

RSS Feed

Enter the URL below into your favorite RSS reader.

https://jheor.org/feed
×
Infectious Diseases
Vol. 3, Issue 2, 2016 October 19, 2015 EDT

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants

Santiago Grau , Carlos Solano , Carol García-Vidal , Isidro Jarque , Jon A. Barrueta , Carmen Peral , Irene Rodríguez , Darío Rubio-Rodríguez , Carlos Rubio-Terrés ,
  • cost-effectiveness analysis
  • micafungin
  • posaconazole
  • voriconazole
  • allogeneic hematopoietic stem cell transplant
  • prophylaxis
  • invasive fungal infections
ccby-4.0 • https://doi.org/10.36469/9832
JHEOR
1.
Grau S, Solano C, García-Vidal C, et al. Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants. JHEOR. 2015;3(2):153-161. doi:10.36469/9832
Save article as...▾
  • PDF
  • XML
  • Citation (BibTeX)
Powered by Scholastica, the modern academic journal management system